Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

This study is not yet open for participant recruitment.
Verified July 2012 by Hospital do Rim e Hipertensão
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Helio Tedesco Silva Junior, Hospital do Rim e Hipertensão
ClinicalTrials.gov Identifier:
NCT01653041
First received: July 26, 2012
Last updated: NA
Last verified: July 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)